The Efficacy of Shielding Systems for Reducing Operator Exposure during Neurointerventional Procedures: A Real-World Prospective Study

被引:2
|
作者
Miller, T. R. [1 ,2 ]
Zhuo, J. [1 ,2 ]
Jindal, G. [1 ,2 ]
Shivashankar, R. [1 ,2 ]
Beaty, N. [3 ]
Gandhi, D. [1 ,2 ]
机构
[1] Univ Maryland, Med Ctr, Dept Diagnost Radiol, Baltimore, MD 21201 USA
[2] Univ Maryland, Med Ctr, Dept Neuroradiol, Baltimore, MD 21201 USA
[3] Univ Maryland, Med Ctr, Dept Neurosurg, Baltimore, MD 21201 USA
关键词
RADIATION-ABSORBING SHIELD; INTERVENTIONAL NEURORADIOLOGY; DOSE REDUCTION; PATIENT; ANGIOGRAPHY; DRAPE; STERILE; TUMORS; BRAIN; RISK;
D O I
10.3174/ajnr.A5038
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Neurointerventional surgery may expose patients and physician operators to substantial amounts of ionizing radiation. Although strategies for reducing patient exposure have been explored in the medical literature, there has been relatively little published in regards to decreasing operator exposure. The purpose of this study was to evaluate the efficacy of shielding systems in reducing physician exposure in a modern neurointerventional practice. MATERIALS AND METHODS: Informed consent was obtained from operators for this Health Insurance Portability and Accountability Act-compliant, institutional review board-approved study. Operator radiation exposure was prospectively measured during 60 consecutive neurointerventional procedures from October to November 2013 using a 3-part lead shielding system. Exposure was then evaluated without lead shielding in a second 60-procedure block from April to May 2014. A radiation protection drape was randomly selected for use in half of the cases in each block. Two-way analysis of covariance was performed to test the effect of shielding systems on operator exposure while controlling for other covariates, including procedure dose-area product. RESULTS: Mean operator procedure dose was 20.6 Sv for the entire cohort and 17.7 Sv when using some type of shielding. Operator exposure significantly correlated with procedure dose-area product, but not with other covariates. After we adjusted for procedure dose-area product, the use of lead shielding or a radiation protection drape significantly reduced operator exposure by 45% (F = 12.54, P < .0001) and 29% (F = 7.02, P = .009), respectively. The difference in protection afforded by these systems was not statistically significant (P = .46), and their adjunctive use did not provide additional protection. CONCLUSIONS: Extensive lead shielding should be used as much as possible in neurointerventional surgery to reduce operator radiation exposure to acceptable levels. A radiation protection drape is a reasonable alternative when standard lead shielding is unavailable or impractical to use without neglecting strategies to minimize the dose.
引用
收藏
页码:450 / 454
页数:5
相关论文
共 50 条
  • [31] Long-term efficacy and safety of bimekizumab in real-world setting: a 52-week prospective study
    Potestio, Luca
    Ruggiero, Angelo
    Martora, Fabrizio
    Megna, Matteo
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 317 (01)
  • [32] The safety and efficacy of surufatinib for the treatment of advanced neuroendocrine tumors: A prospective, multi-center, real-world study
    Jiang, L.
    Chuntao, W.
    Beiyuan, H.
    Tao, C.
    Haitao, G.
    Hanguang, D.
    Jiuliang, Y.
    Zihao, Q.
    Zheng, W.
    Chao, Z.
    Jiancai, Z.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 239 - 239
  • [33] A real-world prospective observational study of eptinezumab in Asian patients with migraine
    Zhao, Yi Jing
    Ong, Jonathan Jia Yuan
    Sonu, Sumit Kumar
    Dang, Jiaojiao
    Ng, Chai Ching
    Herr, Keira Joann
    Bose, Rohini
    Jion, Yasmin Idu
    HEADACHE, 2024, 64 (07): : 810 - 824
  • [34] Wearing-off effect of onabotulinumtoxinA: A prospective real-world study
    Navarro-Perez, M. P.
    Marin-Labanda, R.
    Ballesta-Martinez, S.
    Espinosa-Rueda, J.
    Bellosta-Diago, E.
    Santos-Lasaosa, S.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 166 - 167
  • [35] A prospective, multicenter, real-world study of apatinib in the treatment of gastric cancer
    Xiong, J.
    Yang, J.
    Li, W.
    Xiong, H.
    Liu, G.
    Wu, F.
    Fan, N.
    Zeng, X.
    Huang, F.
    Yang, L.
    Tu, X.
    Shi, C.
    Yi, B.
    Ye, J.
    Li, P.
    Tang, C.
    Huang, J.
    Hou, P.
    Zang, W.
    Tan, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1060 - S1061
  • [36] Gender and bleeding in atrial fibrillation: a real-world prospective cohort study
    Focks, J. J.
    Seelig, J.
    van Vugt, S. P.
    Serne, A. W.
    de Vries, L. B.
    Albers-Akkers, M. T.
    Verheugt, F. W.
    Brouwer, M. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 884 - 885
  • [37] Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors
    Hurkmans, Daan P.
    Sassen, Sebastiaan D. T.
    de Joode, Karlijn
    Putter, Lisanne
    Basak, Edwin A.
    Wijkhuijs, Annemarie J. M.
    Joerger, Markus
    Debets, Reno
    Koch, Birgit C. P.
    Van der Leest, Cor H.
    Schreurs, Marco W. J.
    van der Veldt, Astrid A. M.
    Aerts, Joachim G. J., V
    Mathijssen, Ron H. J.
    Koolen, Stijn L. W.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
  • [38] Wearing-off effect of onabotulinumtoxinA: A prospective real-world study
    Navarro-Perez, M. P.
    Marin-Labanda, R.
    Ballesta-Martinez, S.
    Espinosa-Rueda, J.
    Bellosta-Diago, E.
    Santos-Lasaosa, S.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 112 - 112
  • [39] Safety of acupotomy in a real-world setting: A prospective pilot and feasibility study
    Yoon, Sang-Hoon
    Kwon, Chan -Young
    Jo, Hee-Geun
    Sul, Jae-Uk
    Lee, Hyangsook
    Won, Jiyoon
    Jeong, Su Jin
    Lee, Jun-Hwan
    Leem, Jungtae
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2022, 20 (06): : 514 - 523
  • [40] Safety of acupotomy in a real-world setting: A prospective pilot and feasibility study
    Sang-Hoon Yoon
    Chan-Young Kwon
    Hee-Geun Jo
    Jae-Uk Sul
    Hyangsook Lee
    Jiyoon Won
    Su Jin Jeong
    Jun-Hwan Lee
    Jungtae Leem
    Journal of Integrative Medicine, 2022, 20 (06) : 514 - 523